MBIO
Mustang Bio, Inc.
Price Chart
Latest Quote
$0.70
+0.01 (+1.01%)
Current Price
| Previous Close | $0.69 |
| Open | $0.66 |
| Day High | $0.70 |
| Day Low | $0.66 |
| Volume | 59,460 |
Stock Information
| Shares Outstanding | 6.73M |
| Cash Equivalents | $16.26M |
| Net Income | $-2.72M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $5.30M |
| EPS (TTM) | $-0.48 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-10.96M |
| Income | $-2.72M |
| Book/sh | $1.14 |
| Cash/sh | $2.41 |
| Employees | 4 |
Financial Ratios
| Quick Ratio | 2.10 |
| Current Ratio | 2.12 |
Returns & Margins
| ROA | -12.85% |
| ROE | -44.62% |
Ownership
| Insider Ownership | 4.30% |
| Institutional Ownership | 9.47% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.00 |
| P/B | 0.62 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.71 |
| SMA50 | $0.71 |
| SMA200 | $1.05 |
| RSI | 45.49 |
| ATR | 0.0826 |
| Shares Float | 5.35M |
| Short Float | 0.81% |
| Short Ratio | 1.28 |
| Volatility | 2.08 |
| Rel Volume | 0.18 |
Performance History
| Week | -0.43% |
| Month | +10.76% |
| Quarter | -13.47% |
| 6 Months | -35.78% |
| YTD | -34.58% |
| Year | -32.04% |
| 3 Years | -99.83% |
| 5 Years | -99.97% |
| 10 Years | -99.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $0.70 | 59,500 |
| 2026-06-23 | $0.69 | 90,900 |
| 2026-06-22 | $0.67 | 33,400 |
| 2026-06-18 | $0.65 | 96,800 |
| 2026-06-17 | $0.73 | 25,900 |
| 2026-06-16 | $0.70 | 76,700 |
| 2026-06-15 | $0.74 | 65,800 |
| 2026-06-12 | $0.74 | 45,700 |
| 2026-06-11 | $0.80 | 74,300 |
| 2026-06-10 | $0.74 | 89,700 |
| 2026-06-09 | $0.74 | 131,600 |
| 2026-06-08 | $0.70 | 283,200 |
| 2026-06-05 | $0.67 | 5,028,500 |
| 2026-06-04 | $0.69 | 28,000 |
| 2026-06-03 | $0.74 | 72,800 |
| 2026-06-02 | $0.76 | 124,500 |
| 2026-06-01 | $0.77 | 176,600 |
| 2026-05-29 | $0.67 | 40,500 |
| 2026-05-28 | $0.63 | 26,700 |
| 2026-05-27 | $0.64 | 37,500 |
| 2026-05-26 | $0.62 | 32,400 |
About Mustang Bio, Inc.
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $2,432,000 | $12,553,000 | $50,726,000 | $76,159,000 |
| Net Non Operating Interest Income Expense | $511,000 | $179,000 | $-463,000 | $-2,670,000 |
| Operating Expense | $2,432,000 | $12,553,000 | $50,726,000 | $76,159,000 |
| General And Administrative Expense | $3,948,000 | $4,135,000 | $9,686,000 | $12,210,000 |
| Interest Expense | - | $5,000 | $1,313,000 | $3,359,000 |
| Other Income Expense | - | $-3,378,000 | $-413,000 | $1,304,000 |
| Other Non Operating Income Expenses | - | $314,000 | $917,000 | $1,304,000 |
| Interest Expense Non Operating | - | $5,000 | $1,313,000 | $3,359,000 |
| Other Operating Expenses | - | - | - | $-1,304,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Net Interest Income | $511,000 | $179,000 | $-463,000 | $-2,670,000 |
| Interest Income | $511,000 | $179,000 | $850,000 | $689,000 |
| Normalized Income | $-1,921,000 | $-12,060,000 | $-50,272,000 | $-77,525,000 |
| Net Income From Continuing And Discontinued Operation | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Total Operating Income As Reported | $-2,432,000 | $-16,245,000 | $-49,260,000 | $-76,159,000 |
| Net Income Common Stockholders | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Net Income | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Net Income Including Noncontrolling Interests | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Net Income Continuous Operations | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Pretax Income | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Special Income Charges | $0 | $-3,692,000 | $-1,330,000 | $0 |
| Interest Income Non Operating | $511,000 | $179,000 | $850,000 | $689,000 |
| Operating Income | $-2,432,000 | $-12,553,000 | $-50,726,000 | $-76,159,000 |
| Per Share | ||||
| Diluted EPS | $-0.39 | $-38.57 | $-299.95 | $-562.50 |
| Basic EPS | $-0.39 | $-38.57 | $-299.95 | $-562.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,391,000 | $-8,038,000 | $-46,734,000 | $-71,135,000 |
| Total Unusual Items | $0 | $-3,692,000 | $-1,330,000 | $0 |
| Total Unusual Items Excluding Goodwill | $0 | $-3,692,000 | $-1,330,000 | $0 |
| Reconciled Depreciation | $41,000 | $823,000 | $2,225,000 | $3,031,000 |
| EBITDA (Bullshit earnings) | $-2,391,000 | $-11,730,000 | $-48,064,000 | $-71,135,000 |
| EBIT | $-2,432,000 | $-12,553,000 | $-50,289,000 | $-74,166,000 |
| Diluted Average Shares | $4,908,164 | $609,696 | $172,031 | $137,910 |
| Basic Average Shares | $4,908,164 | $609,696 | $172,031 | $137,910 |
| Diluted NI Availto Com Stockholders | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Impairment Of Capital Assets | $0 | $3,692,000 | $0 | - |
| Research And Development | $-1,516,000 | $8,418,000 | $41,040,000 | $63,949,000 |
| Selling General And Administration | $3,948,000 | $4,135,000 | $9,686,000 | $12,210,000 |
| Other Gand A | $3,948,000 | $4,135,000 | $9,686,000 | $12,210,000 |
| Gain On Sale Of Ppe | - | $0 | $1,466,000 | $0 |
| Write Off | - | $3,692,000 | $0 | - |
| Other Special Charges | - | - | $2,796,000 | - |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $9,529,000 | $-3,873,000 | $123,000 | $46,273,000 |
| Total Assets | $17,593,000 | $9,308,000 | $17,742,000 | $92,422,000 |
| Total Non Current Assets | $0 | $702,000 | $6,396,000 | $13,570,000 |
| Current Assets | $17,593,000 | $8,606,000 | $11,346,000 | $78,852,000 |
| Other Current Assets | $110,000 | $200,000 | $1,233,000 | $2,897,000 |
| Assets Held For Sale Current | $0 | $1,165,000 | $0 | - |
| Receivables | $217,000 | $402,000 | $3,879,000 | $299,000 |
| Other Receivables | $217,000 | $402,000 | $3,879,000 | $263,000 |
| Cash Cash Equivalents And Short Term Investments | $17,266,000 | $6,839,000 | $6,234,000 | $75,656,000 |
| Cash And Cash Equivalents | $17,266,000 | $6,839,000 | $6,234,000 | $75,656,000 |
| Other Non Current Assets | - | $250,000 | $1,583,000 | $1,261,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $0 | $878,000 | $2,498,000 | $31,382,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $422,000 | $1,978,000 | $30,770,000 |
| Current Debt And Capital Lease Obligation | - | $456,000 | $520,000 | $612,000 |
| Long Term Debt | - | - | - | $27,436,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,064,000 | $13,181,000 | $17,619,000 | $46,149,000 |
| Total Non Current Liabilities Net Minority Interest | $150,000 | $572,000 | $2,248,000 | $31,040,000 |
| Non Current Deferred Liabilities | $150,000 | $150,000 | $270,000 | $270,000 |
| Current Liabilities | $7,914,000 | $12,609,000 | $15,371,000 | $15,109,000 |
| Payables And Accrued Expenses | $7,890,000 | $12,060,000 | $12,013,000 | $11,029,000 |
| Payables | $6,013,000 | $10,131,000 | $7,156,000 | $7,599,000 |
| Accounts Payable | $3,510,000 | $7,464,000 | $6,322,000 | $6,833,000 |
| Equity | ||||
| Common Stock Equity | $9,529,000 | $-3,873,000 | $123,000 | $46,273,000 |
| Total Equity Gross Minority Interest | $9,529,000 | $-3,873,000 | $123,000 | $46,273,000 |
| Stockholders Equity | $9,529,000 | $-3,873,000 | $123,000 | $46,273,000 |
| Other Equity Interest | $273,000 | $611,000 | $591,000 | $1,109,000 |
| Retained Earnings | $-398,644,000 | $-396,723,000 | $-380,971,000 | $-329,369,000 |
| Other | ||||
| Preferred Shares Number | $250,000 | $250,000 | $250,000 | $250,000 |
| Ordinary Shares Number | $7,299,086 | $1,831,357 | $1,012,882 | $198,361 |
| Share Issued | $7,299,086 | $1,831,357 | $1,012,882 | $198,361 |
| Tangible Book Value | $9,529,000 | $-3,873,000 | $123,000 | $46,273,000 |
| Invested Capital | $9,529,000 | $-3,873,000 | $123,000 | $73,709,000 |
| Working Capital | $9,679,000 | $-4,003,000 | $-4,025,000 | $63,743,000 |
| Capital Lease Obligations | $0 | $878,000 | $2,498,000 | $3,946,000 |
| Total Capitalization | $9,529,000 | $-3,873,000 | $123,000 | $73,709,000 |
| Additional Paid In Capital | $407,899,000 | $392,234,000 | $380,502,000 | $374,522,000 |
| Capital Stock | $1,000 | $5,000 | $1,000 | $11,000 |
| Common Stock | $1,000 | $5,000 | $1,000 | $11,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $150,000 | $150,000 | $270,000 | $270,000 |
| Long Term Capital Lease Obligation | $0 | $422,000 | $1,978,000 | $3,334,000 |
| Current Capital Lease Obligation | $0 | $456,000 | $520,000 | $612,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $24,000 | $93,000 | $2,838,000 | $3,468,000 |
| Current Accrued Expenses | $1,877,000 | $1,929,000 | $4,857,000 | $3,430,000 |
| Dueto Related Parties Current | $2,503,000 | $2,667,000 | $834,000 | $766,000 |
| Net PPE | $0 | $452,000 | $4,813,000 | $12,309,000 |
| Gross PPE | $0 | $452,000 | $9,289,000 | $20,710,000 |
| Leases | $0 | $371,000 | $7,694,000 | $7,694,000 |
| Properties | $0 | $0 | $0 | $0 |
| Accumulated Depreciation | - | $-7,323,000 | $-4,476,000 | $-8,401,000 |
| Construction In Progress | - | $0 | $29,000 | $951,000 |
| Other Properties | - | $81,000 | $1,566,000 | $2,918,000 |
| Treasury Shares Number | - | - | $0 | - |
| Machinery Furniture Equipment | - | - | $0 | $9,147,000 |
| Duefrom Related Parties Current | - | - | $0 | $36,000 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,264,000 | $-11,410,000 | $-49,591,000 | $-68,145,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,264,000 | $-11,410,000 | $-49,477,000 | $-65,066,000 |
| Cash Flow From Continuing Operating Activities | $-5,264,000 | $-11,410,000 | $-49,476,000 | $-65,066,000 |
| Operating Gains Losses | - | $29,000 | $1,330,000 | $255,000 |
| Investing Activities | ||||
| Investing Cash Flow | $1,165,000 | $0 | $5,886,000 | $-2,952,000 |
| Cash Flow From Continuing Investing Activities | $1,165,000 | $0 | $5,886,000 | $-2,952,000 |
| Capital Expenditure | - | - | $-114,000 | $-3,079,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,381,000 | $7,694,000 | $4,561,000 | $6,623,000 |
| Financing Cash Flow | $14,526,000 | $11,265,000 | $-26,081,000 | $34,056,000 |
| Cash Flow From Continuing Financing Activities | $14,526,000 | $11,265,000 | $-26,082,000 | $34,056,000 |
| Net Common Stock Issuance | $7,381,000 | $7,694,000 | $4,561,000 | $6,623,000 |
| Common Stock Issuance | $7,381,000 | $7,694,000 | $4,561,000 | $6,623,000 |
| Net Other Financing Charges | - | $-1,455,000 | $-445,000 | $-2,773,000 |
| Other | ||||
| End Cash Position | $17,266,000 | $6,839,000 | $6,984,000 | $76,656,000 |
| Beginning Cash Position | $6,839,000 | $6,984,000 | $76,656,000 | $110,618,000 |
| Changes In Cash | $10,427,000 | $-145,000 | $-69,672,000 | $-33,962,000 |
| Proceeds From Stock Option Exercised | $7,145,000 | $3,571,000 | $178,000 | $206,000 |
| Net PPE Purchase And Sale | $1,165,000 | $0 | $5,936,000 | $-2,587,000 |
| Sale Of PPE | $1,165,000 | $0 | $6,000,000 | $127,000 |
| Change In Working Capital | $-1,683,000 | $1,755,000 | $-2,976,000 | $4,030,000 |
| Change In Other Current Liabilities | $-73,000 | $-447,000 | $-680,000 | $-263,000 |
| Change In Payables And Accrued Expense | $-2,135,000 | $1,242,000 | $192,000 | $5,300,000 |
| Change In Prepaid Assets | $90,000 | $586,000 | $1,092,000 | $-1,006,000 |
| Change In Receivables | $435,000 | $494,000 | $-3,580,000 | $-1,000 |
| Other Non Cash Items | $-1,830,000 | $-1,507,000 | $978,000 | $2,860,000 |
| Stock Based Compensation | $129,000 | $-450,000 | $568,000 | $2,283,000 |
| Asset Impairment Charge | $0 | $3,692,000 | $0 | - |
| Depreciation Amortization Depletion | $41,000 | $823,000 | $2,225,000 | $3,031,000 |
| Depreciation And Amortization | $41,000 | $823,000 | $2,225,000 | $3,031,000 |
| Depreciation | $41,000 | $823,000 | $2,225,000 | $3,031,000 |
| Gain Loss On Sale Of PPE | $0 | $29,000 | $-1,466,000 | $255,000 |
| Net Income From Continuing Operations | $-1,921,000 | $-15,752,000 | $-51,602,000 | $-77,525,000 |
| Repayment Of Debt | - | $0 | $-30,375,000 | $0 |
| Interest Paid Supplemental Data | - | $0 | $1,340,000 | $2,710,000 |
| Net Issuance Payments Of Debt | - | $0 | $-30,375,000 | $30,000,000 |
| Net Short Term Debt Issuance | - | $0 | $-30,375,000 | - |
| Short Term Debt Payments | - | $0 | $-30,375,000 | - |
| Net Intangibles Purchase And Sale | - | $0 | $-50,000 | $-365,000 |
| Purchase Of Intangibles | - | $0 | $-50,000 | $-365,000 |
| Purchase Of PPE | - | $0 | $-64,000 | $-2,714,000 |
| Change In Other Working Capital | - | $-120,000 | - | - |
| Issuance Of Debt | - | - | $0 | $30,000,000 |
| Net Long Term Debt Issuance | - | - | $-30,375,000 | $30,000,000 |
| Long Term Debt Payments | - | - | $-30,375,000 | $0 |
| Long Term Debt Issuance | - | - | $0 | $30,000,000 |
| Change In Payable | - | - | $192,000 | $5,300,000 |
| Change In Account Payable | - | - | $192,000 | $5,300,000 |
Fetched: 2026-06-20